MedPath

Evaluation of nifedipine administration on embyro transfer success rate, a Randomized Clinical Trial

Phase 1
Conditions
Female infertility.
Female infertility
Registration Number
IRCT20201129049532N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
98
Inclusion Criteria

Women aged 18-40 with primary or secondary infertility
fresh or frozen embryo transfer
good embryo quality(based on defined criteria)
transfer of 3 embryo of two days age

Exclusion Criteria

Blood pressure less than 100/60mmHg
Body mass index > 38 kg/m2
Abnormal uterine cavity(congenital or acquired)
Nifedipine contraindications(history of severe allergic reaction, porphyria, severe heart failure)
Recurrent implantation failure
History of recurrent abortion

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Pregnancy. Timepoint: Before intervention and 3 weeks after intervention. Method of measurement: Transvaginal ultrasound and serum Bhcg.
Secondary Outcome Measures
NameTimeMethod
ive birth, multiple gestation, abortion. Timepoint: 3 weeks after intervention, 9 months after intervention if primaryboutcome occured. Method of measurement: Transvaginal ultrasound, successful delivery.
© Copyright 2025. All Rights Reserved by MedPath